Navigation Links
ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
Date:3/18/2009

o the point of ignoring the cautionary statements contained in the very authority cited by OGD as scientific support for its method, as well as the advice of its own experts.
  • When faced with a safety issue identified in Vancocin's labeling and by its own 2008 advisory committee - the potential for systemic absorption of the drug at toxic levels and the need for pharmacokinetic (PK) testing to address that safety issue - OGD again turned away from patients with CDI. Instead, they concluded that PK testing is unnecessary because the drug is not absorbed in healthy patients who are not infected with CDI.
  • By focusing exclusively on the lower GI tract, the December 2008 Draft Guidance fails to account for another indicated use of Vancocin - Staphylococcus aureus GI infections - which occur in both the upper and lower GI tract.
  • OGD's Q1Q2 sameness standard is flawed and incomplete. OGD acknowledges that inactive ingredients may affect product performance, and that the state of knowledge in this area is underdeveloped. However, OGD proposes without explanation that a Q1Q2 standard developed for oral solutions will nonetheless apply to Vancocin, an oral capsule product. Then, OGD backs off the sameness supposedly ensured by the Q1Q2 standard, and permits generic applicants to vary their inactive ingredients in the absence of any standards to evaluate the effect of such variations on the generic product's performance.
  • "OGD's extensive litany of errors and omissions not only required an equally extensive response, but should cause many to question, as we do, whether OGD has abrogated its decision-making role in bioequivalence method development for Vancocin," continued Doyle.

    While ViroPharma's comments note that numerous flaws prevent use of OGD's proposed new BE method for Vancocin, ViroPharma also believes that, even if the new method was valid, OGD's a
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
    2. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
    3. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
    4. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
    5. ViroPharma Announces Discontinuation of HCV-796 Development
    6. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
    7. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
    8. ViroPharma to Present at the Natixis Bleichroeder Conference
    9. ViroPharma to Present at Three Upcoming Healthcare Conferences
    10. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
    11. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... , July 29, 2015 ... Therapeutic Vaccines Market - Growth, Trends & Forecasts (2015-2020) ... expected to be worth US$ 2.85 billion by the ... being the largest market globally accounting for more ... market for Therapeutic Vaccines is expected to grow at ...
    (Date:7/28/2015)... 2015   Heska Corporation  (NASDAQ:  HSKA -  News ... advanced veterinary diagnostic and other specialty veterinary products ... Element i ® Immunodiagnostic Analyzer. Element i ... health concerns, including thyroid disorders, Cushing,s disease and ... bench top analyzer that delivers rapid immunoassay testing, ...
    (Date:7/28/2015)... , July 28, 2015 On the afternoon ... parent company of CPI International, Inc. (CPI), plans to ... July 3, 2015 with the Securities and Exchange Commission ... for the quarter.  At 11 a.m. (EDT) on Wednesday, ... call in conjunction with this release that will be ...
    Breaking Medicine Technology:New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 2New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 3Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3CPI International To Announce Third Quarter 2015 Financial Results 2
    ... Reportlinker.com announces that a new market ... Germany Surgical Equipment Market ... http://www.reportlinker.com/p0254518/Germany-Surgical-Equipment-Market-Outlook-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Germany Surgical Equipment ... Summary GlobalData,s new report, ...
    ... OSLO, Norway, October 31, 2011 Oslo ... oncology. The true strength of the Norwegian cluster lies ... than the ones available to cancer patients today. ... cluster within the field of oncology, dedicated to accelerating ...
    Cached Medicine Technology:Germany Surgical Equipment Market Outlook to 2016 2Germany Surgical Equipment Market Outlook to 2016 3Germany Surgical Equipment Market Outlook to 2016 4Germany Surgical Equipment Market Outlook to 2016 5Germany Surgical Equipment Market Outlook to 2016 6Germany Surgical Equipment Market Outlook to 2016 7Germany Surgical Equipment Market Outlook to 2016 8Germany Surgical Equipment Market Outlook to 2016 9Expanding Norwegian Cluster of Excellence Dedicated to Oncology 2Expanding Norwegian Cluster of Excellence Dedicated to Oncology 3
    (Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful teaching ... W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in Beverly ... need. , “We are thrilled for this opportunity to offer prolotherapy treatments for ...
    (Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... first two patients in a Clinical Performance Study for the Invisiport at Wheaton ... and 6 French catheter options, offers a less invasive, patient-friendly alternative to traditional ...
    (Date:7/29/2015)... ... July 29, 2015 , ... ... the Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling ... their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical ...
    (Date:7/29/2015)... ... ... Woodlands and Spring Fit Body Boot Camps have implemented an engaging an interactive way ... system will track each time a client uses social media to Check In at ... will donate 20 cents to a selected charity. , Fit Body Boot Camp is ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for ... also the home of Zerorez Indianapolis, which plans to expand across the state. , ... is our second full year in business and we should double our first year’s ...
    Breaking Medicine News(10 mins):Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3
    ... 9 December, 2010 The 19th International Conference ... an Elsevier company and leader in assisting healthcare organizations ... on transformational leadership and feature advice from many business ... Inc.. "The essence of transformation, real innovation ...
    ... Gardner HealthDay Reporter , WEDNESDAY, Dec. 8 ... doesn,t cause breast cancer survivors to develop the painful, ... There,s a hint that weight-lifting might even help prevent ... for sure, the researchers said. Breast cancer-related lymphedema ...
    ... a key role in the prevention of the painful ... new research from the University of Pennsylvania School of ... exercise limits a worsening of symptoms among women who ... of long-running advice that breast cancer survivors should avoid ...
    ... December 8, 2010) A school-based intervention program helped ... severe asthma better manage their symptoms, dramatically reducing the ... visits, according to a study published online in the ... . Students in the eight-week program reported ...
    ... 2010) Jeffrey S. Upperman, MD, director of the ... call to action for filling a significant gap in pediatric ... framework for a pediatric applied trauma research network (PATRN). ... Journal of Pediatric Surgery and the Journal of ...
    ... HealthDay Reporter , WEDNESDAY, Dec. 8 (HealthDay News) ... gift shopping and open enrollment, when many employees have ... Last year,s landmark health care reform legislation means changes ... significant: starting Jan. 1, you,ll no longer be able ...
    Cached Medicine News:Health News:Transformation at top of agenda for CPMRC's annual conference in Jan. 2011 2Health News:Weight-Lifting After Breast Cancer Won't Cause Lymphedema, Study Finds 2Health News:Weight-Lifting After Breast Cancer Won't Cause Lymphedema, Study Finds 3Health News:Weightlifting slashes lymphedema risk after breast cancer treatment 2Health News:Weightlifting slashes lymphedema risk after breast cancer treatment 3Health News:School-based program effective in helping adolescents 2Health News:Trauma surgeon leads call to action for pediatric applied trauma research network 2Health News:Changes to Flex Spending Accounts Could Hurt Consumers 2Health News:Changes to Flex Spending Accounts Could Hurt Consumers 3
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: